Buy SLU-PP-332 (250mcg x 50 Capsules) Research Capsules OnlineA lower-dose capsule formulation of SLU-PP-332, this preparation delivers the selective estrogen-related receptor agonist at 250 microgram unit doses within vegetable cellulose capsules across 50-count container. This configuration supports pilot-phase preclinical research and dose-optimization studies requiring conservative compound quantities. The capsule matrix maintains pharmacological activity while providing convenient oral gavage administration suitable for rodent metabolic research.SLU-PP-332 (250mcg x 50 Capsules) Mechanism of ActionSLU-PP-332 functions as a selective ERRα/γ agonist, engaging orphan nuclear receptor pathways that regulate mitochondrial biogenesis and metabolic homeostasis in laboratory animal tissues. Preclinical studies document the 250 microgram capsule dosage achieving adequate drug exposure for metabolic and mitochondrial function investigations in rodent models. The selective ERR engagement mechanism operates distinctly from classical estrogen receptor pathways, permitting investigation of ERR-specific biological functions.SLU-PP-332 (250mcg x 50 Capsules) Published Research SummaryPublished preclinical literature details SLU-PP-332 capsule formulation bioavailability and pharmacokinetics in mouse and rat models. Research documents oral absorption kinetics and plasma concentration profiles, establishing that capsule delivery achieves ERR receptor occupancy in target tissues. Animal studies characterize dose-dependent metabolic responses and mitochondrial function modulation following capsule administration.The 50-capsule supply accommodates research studies requiring initial dose-finding protocols or limited-duration investigations. The 250 microgram unit dose provides flexible scaling for rodent body weight ranges and enables gradient dosing strategies examining concentration-dependent ERR agonism effects on metabolic parameters.SLU-PP-332 (250mcg x 50 Capsules) Product Specifications & StorageStorage requires room temperature (20-25°C) in dry conditions protected from light and moisture. Capsule formulations maintain stability for extended periods under appropriate storage protocols. Document all usage according to institutional animal care and research guidelines.SLU-PP-332 (250mcg x 50 Capsules) Research Use Only DisclaimerDISCLAIMER: Exclusively for preclinical research and educational purposes. Not for human consumption, therapeutic intervention, or medical application. All documented effects from animal studies exclusively. Full institutional compliance and regulatory adherence required.
